Clinical trials: Prostatic Artery Embolization
Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms
Prostatic Artery Embolization for the Treatment of Symptomatic Benign Prostatic Hyperplasia (BPH)
This is a single center, prospective, investigational study to evaluate the safety and efficacy of prostatic artery embolization (PAE) for the treatment of moderate to severe lower urinary tract symptoms (LUTS) due to benign…
- Trial name
- NCT04563221
- Testing
- Prostatic artery embolization
- Where
- United States
- Sponsor
- Andrew Picel
Prostatic Hyperplasia
Prostate Artery Embolization for the Treatment of Benign Prostatic Hyperplasia
The primary study objective is to evaluate improvement of symptoms from benign prostatic hyperplasia (BPH) as assessed by the International Prostate Symptom Score (IPSS) at 12 months post prostatic artery embolization (PAE) with…
- Trial name
- NCT03179228
- Testing
- Prostate Embolization
- Where
- United States
- Volunteers
- healthy volunteers welcome
- Sponsor
- John D Louie
Prostate Adenocarcinoma, Obesity, Morbid
Bariatric Arterial Embolization for Men Starting Hormones for Prostate Cancer
The standard of care for obese men starting Androgen deprivation therapy (ADT) is physician based dietary and exercise counseling. Interventions to lessen the harmful effects of ADT are needed yet have been limited.
- Trial name
- BASH-PC (NCT04331717)
- Testing
- Bead Block 300-500 um, Weight Management, Lupron
- Where
- United States
- Volunteers
- healthy volunteers welcome
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Prostatic Hyperplasia, Lower Urinary Tract Symptoms
Clinical Trial on the Effectiveness of TUMT Compared to PAE in Reducing Severe LUTS in Men with BPH
The TUMT-PAE-1 trial is a randomised clinical trial aiming to compare the effectiveness of transurethral microwave thermotherapy (TUMT) with prostatic artery embolisation (PAE) in reducing urinary symptoms caused by prostate…
- Trial name
- TUMT-PAE-1 (NCT05686525)
- Testing
- Transurethral Microwave Thermotherapy, Prostate Artery Embolisation
- Where
- 3 sites in Denmark
- Volunteers
- 220 people
- Sponsor
- Copenhagen University Hospital, Rigshospitalet
Lower Urinary Tract Symptom, Benign Prostatic Hyperplasia (BPH)
Taiwan ACE Beads for Embolization Therapy in Symptomatic Benign Prostatic Hyperplasia
In this proposal, the investigators plan to conduct a clinical trial to validate the efficacy and safety of microspheres (T-ACE Beads).
- Trial name
- NCT03239652
- Testing
- Taiwan ACE Beads
- Where
- Taiwan
- Volunteers
- 12 people
- Sponsor
- National Cheng-Kung University Hospital
Benign Prostate Hyperplasia
Prostatic Artery Embolization for Benign Prostatic Hyperplasia
To evaluate whether Prostatic Artery Embolization (PAE) might be an effective alternative treatment option for benign prostatic hyperplasia (BPH), in comparison to current gold standard surgical treatment- Transurethral Resection…
- Trial name
- NCT01835860
- Testing
- Prostate artery embolization
- Where
- Canada
- Volunteers
- 13 people
- Sponsor
- Saskatchewan Health Authority - Regina Area
Benign Prostatic Hyperplasia (BPH)
Prostatic Artery Embolization (PAE) for Treatment of Benign Prostatic Hyperplasia (BPH)
This is an open-labeled, non-randomized feasibility study to evaluate the safety of prostate artery embolization (PAE) for the treatment of lower urinary tract symptoms attributed to benign prostatic hyperplasia (BPH).
- Trial name
- NCT02026908
- Testing
- Prostate Artery Embolization
- Where
- United States
- Volunteers
- 45 people
- Sponsor
- Northwestern University
Prostatic Hyperplasia, Benign
Prostatic Arterial Embolization With SQUID (Ethylene Vinyl Alcohol Copolymer )
The aim of this pilot study is to analyze the feasibility of prostatic embolization for the treatment of symptomatic benign prostatic hypertrophy with a non adhesive liquid embolic agent (Squid)
- Trial name
- SQUID (NCT05395299)
- Testing
- SQUID (Ethylene Vinyl Alcohol Copolymer ) administred to the participant with the intervention Prostatic Arterial Embolization
- Where
- France
- Volunteers
- 12 people
- Sponsor
- Centre Hospitalier Universitaire de Nice
Benign Prostatic Hyperplasia
Use of a Novel Radiopaque Embolic Agent in Prostatic Artery Embolisation for Symptomatic Benign Prostatic Enlargement
This is a study protocol for the use of a novel radiopaque embolic agent in the treatment of lower urinary tract Symptoms (LUTS) with prostatic artery embolisation (PAE).
- Trial name
- NCT03109925
- Testing
- DC Lumi Bead, BTG
- Where
- United Kingdom
- Volunteers
- 23 people
- Sponsor
- University Hospital Southampton NHS Foundation Trust
Benign Prostatic Hyperplasia
Investigation of Prostate Artery Embolization Compared to Holmium Laser Enucleation of Prostate
The purpose of this research study is to evaluate prostate artery embolization (PAE) compared to Holmium laser enucleation of prostate (HoLEP) in improving a patient's overall prostate related symptoms.
- Trial name
- NCT05155891
- Testing
- Embosphere Microspheres, HoLEP Procedure
- Where
- United States
- Volunteers
- 45 people
- Sponsor
- University of Miami
Prostatic Hyperplasia
Efficacy of a Single Dose Dexamethasone in Reducing the Postembolization Syndrome in Men Undergoing Prostatic Artery Embolization for Benign Prostatic Hyperplasia
Benign prostatic hyperplasia (BPH) is a frequent cause of lower urinary tract symptoms (LUTS) in men. One fourth of men older than 70 have moderate to severe LUTS that impair their quality of life (QOL).
- Trial name
- NCT04588857
- Testing
- Dexamethasone, Saline
- Where
- Denmark
- Volunteers
- 60 people
- Sponsor
- Copenhagen University Hospital, Rigshospitalet
Prostate Carcinoma, Benign Prostatic Hyperplasia
Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery Embolization
This is a Phase II prospective clinical trial in which patients with prostate carcinoma and obstructive lower urinary tract symptoms electing for radiation therapy will undergo Prostatic Artery Embolization (PAE) prior to…
- Trial name
- NCT04879940
- Testing
- Merit Medical Embospheres, Radiation Therapy
- Where
- United States
- Volunteers
- 17 people
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
Benign Prostatic Hyperplasia
Ga-68 MAA Distribution in PAE Patients
Purpose: The purpose of this study is to evaluate Ga-68 MAA distribution on PET/MRI after injection into the prostatic arteries in patients without prostate cancer who are being treated with prostate artery embolization for…
- Trial name
- NCT04243824
- Testing
- Gallium 68 Macro-aggregated albumin
- Where
- United States
- Sponsor
- University of North Carolina, Chapel Hill
Prostatic Hyperplasia, Benign Prostatic Hyperplasia (BPH)
Prostate Artery Embolization (PAE) for Treatment of Benign Prostatic Hyperplasia
The purpose of this project is to evaluate the safety, efficacy, and feasibility of performing prostatic artery embolization (PAE) using endovascular techniques and particle embolics in men suffering from lower urinary tract…
- Conditions
- Prostatic Hyperplasia, Benign Prostatic Hyperplasia (BPH), Prostatism, Lower Urinary Tract Symptoms (LUTS)
- Trial name
- NCT02592473
- Testing
- Embozene Microspheres
- Where
- United States
- Volunteers
- 50 people
- Sponsor
- University of Virginia
Prostate Cancer
Phase II Investigation of Prostate Artery Embolization (PAE) Before Radical Prostatectomy in Prostate Cancer Patients
The purpose of this study is to determine whether pre-operative prostate artery embolization (PAE) reduces intra-operative blood loss and improves surgical outcomes among prostate cancer patients undergoing robot-assisted…
- Trial name
- NCT02173522
- Testing
- Prostate artery embolization (PAE)
- Where
- United States
- Volunteers
- 4 people
- Sponsor
- Shivank Bhatia
Benign Prostatic Hyperplasia, Benign Prostatic Hypertrophy
Safety and Efficacy of OCL 503 in Prostate Artery Embolization
This is a prospective, pilot, open-label, uncontrolled, non-randomized safety and effectiveness study of OCL 503 in men with BPH.
- Trial name
- NCT02509975
- Testing
- Prostate artery embolization.
- Where
- Canada
- Volunteers
- 10 people
- Sponsor
- IMBiotechnologies Ltd.
Benign Prostatic Hyperplasia
Prostate Artery Embolization Compared to Holmium Laser Enucleation of the Prostate for Benign Prostatic Hyperplasia
The purpose of this study is to evaluate improvement of symptoms from benign prostatic hyperplasia (BPH) as assessed by the International Prostate Symptom Score (IPSS) for prostate artery embolization (PAE) with microspheres…
- Trial name
- NCT04236687
- Testing
- Holmium laser enucleation of the prostate, Artery embolization of the prostate
- Where
- Spain
- Volunteers
- 100 people
- Sponsor
- Germans Trias i Pujol Hospital
Benign Prostatic Hyperplasia
Prostatic Artery Embolization vs. Conventional Transurethral Prostatectomy in the Treatment of Benign Prostatic Hyperplasia
Benign prostatic hyperplasia (BPH) is a prevalent entity, affecting over 50% of men older than 60 years. The clinical picture of the disease includes lower urinary tract symptoms such as interrupted and weak urinary stream…
- Trial name
- NCT02054013
- Testing
- Prostatic artery embolization, monopolar transurethral prostatectomy
- Where
- Switzerland
- Volunteers
- 101 people
- Sponsor
- Daniel Stephan Engeler
Benign Prostatic Hyperplasia
Prostate Artery Embolization With Embosphere Microspheres Compared to TURP for Benign Prostatic Hyperplasia
The purpose of this study is to evaluate improvement of symptoms from benign prostatic hyperplasia (BPH) as assessed by the International Prostate Symptom Score (IPSS) for prostatic artery embolization (PAE) using Embosphere…
- Trial name
- NCT01789840
- Testing
- Embosphere Microspheres, TURP
- Where
- 10 sites in United States
- Volunteers
- 59 people
- Sponsor
- Merit Medical Systems, Inc.
BPH, Enlarged Prostate (BPH)
Prostatic Artery Embolization vs Medication for Benign Prostatic Hyperplasia
Purpose: The purpose of this study is to determine if prostatic artery embolization (PAE) is as effective as medication (non-inferiority) in reducing urinary symptoms due to benign prostatic hyperplasia (BPH) and to determine if…
- Conditions
- BPH, Enlarged Prostate (BPH), Prostatic Hyperplasia
- Trial name
- NCT04398966
- Testing
- Prostatic Artery Embolization (HydroPearl® compressible microspheres)
- Where
- United States
- Volunteers
- 12 people
- Sponsor
- University of North Carolina, Chapel Hill